v3.26.1
STOCK-BASED COMPENSATION
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
Presented below is a summary of the stock-based compensation cost and associated tax benefit included in the accompanying consolidated statements of operations:
Three Months Ended June 30,
Six Months Ended June 30,
2026202520262025
Stock-based compensation cost$60 $61 $117 $118 
Tax benefit$13 $13 $26 $25 
During the first half of 2026, the Company granted 0.1 million employee stock options, which had a weighted average grant date fair value of $133.17 per share. The Company also granted 0.5 million shares of restricted stock in the first half of 2026, which had a weighted average grant date fair value of $443.74 per share. Both the employee stock options and restricted stock generally vest ratably over four years. Additionally, the Company granted 0.1 million shares of performance-based awards whereby the number of shares that ultimately vest is based on the achievement of certain non-market-based performance metrics of the Company over three years. The weighted average grant date fair value of these awards was $431.10 per share.
The following weighted average assumptions were used in determining the fair value using the Black-Scholes option-pricing model for options granted in 2026:
Expected dividend yield0.93 %
Expected stock volatility27 %
Risk-free interest rate3.74 %
Expected holding period5.7 years
Unrecognized stock-based compensation expense at June 30, 2026 was $13 million and $354 million for unvested stock options and restricted stock, respectively, which is expected to be recognized over a weighted average period of 1.9 years and 2.6 years, respectively. Additionally, there was $61 million of unrecognized stock-based compensation expense relating to the aforementioned non-market-based performance-based awards, which is expected to be recognized over a weighted average period of 2.0 years.
The following table summarizes information relating to stock option exercises and restricted stock vesting:
Six months ended June 30,
2026
2025
Exercise of stock options:
Proceeds from stock option exercises$12 $20 
Aggregate intrinsic value$16 $31 
Tax benefit realized upon exercise$4 $7 
Number of shares exercised
0.1 0.1 
Vesting of restricted stock:
Fair value of shares vested$203 $236 
Tax benefit realized upon vesting$49 $58 
Number of shares vested0.4 0.5 
Vesting of performance-based restricted stock:
Fair value of shares vested$72 $8 
Tax benefit realized upon vesting$12 $1 
Number of shares vested (1)
0.2 — 
(1) The number of shares vested in 2025 was approximately 15 thousand.